Latest filing published 16 Sept 2024 for Bicara Therapeutics Inc..
Insider track record
No signal scores available.
Kiran Mazumdar-Shaw: trading record in brief
Kiran Mazumdar-Shaw discloses dealings in Bicara Therapeutics Inc. to SEC (Form 4). We count 4 filings, every one of them for a trade on 16 September 2024.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 16 September 2024: a transaction, in Bicara Therapeutics Inc. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kiran Mazumdar-Shaw
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,080,775 shares0Common StockSEC:0000950170-24-106866:1
- 324,552 shares0Common StockSEC:0000950170-24-106866:2
- 432,736 shares0Common StockSEC:0000950170-24-106866:3
- 4,327,365 shares0Common StockSEC:0000950170-24-106866:0
4 of 4 declarations
